Table of Contents
Leukemia Research and Treatment
Volume 2014, Article ID 143479, 12 pages
http://dx.doi.org/10.1155/2014/143479
Research Article

In Vitro Characterization of Valproic Acid, ATRA, and Cytarabine Used for Disease-Stabilization in Human Acute Myeloid Leukemia: Antiproliferative Effects of Drugs on Endothelial and Osteoblastic Cells and Altered Release of Angioregulatory Mediators by Endothelial Cells

1Department of Clinical Science, Hematology Section, University of Bergen, 5021 Bergen, Norway
2Department of Molecular Biosciences, University of Oslo, 0316 Oslo, Norway
3Department of Biomedicine, University of Bergen, Norway
4Department of Medicine, Haukeland University Hospital, 5021 Bergen, Norway

Received 28 July 2013; Accepted 28 October 2013; Published 8 January 2014

Academic Editor: Judith E. Karp

Copyright © 2014 Hilde Kvestad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hilde Kvestad, Lasse Evensen, James B. Lorens, Øystein Bruserud, and Kimberley J. Hatfield, “In Vitro Characterization of Valproic Acid, ATRA, and Cytarabine Used for Disease-Stabilization in Human Acute Myeloid Leukemia: Antiproliferative Effects of Drugs on Endothelial and Osteoblastic Cells and Altered Release of Angioregulatory Mediators by Endothelial Cells,” Leukemia Research and Treatment, vol. 2014, Article ID 143479, 12 pages, 2014. https://doi.org/10.1155/2014/143479.